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Abstract 
Macrophages are one of the most important types of immune effector cells and are closely 
associated with tumor progression and metastasis. In this work, we investigated the influences 
of oxidized multiwalled carbon nanotubes (o-MWCNT) on macrophages that are resting in 
the normal subcutis tissue or in the tumor microenvironment in vivo as well as on the 
macrophage cell line of RAW 264.7 treated with combination of IL4, IL10 and IL13 in vitro. 
The o-MWCNT were characterized with SEM, DLS, FTIR, TGA, and UV-vis-NIR spectros-
copy, and their effects on the RWA 264.7 cell line and breast cancer tumor-bearing mice were 
analyzed using the MTS assay, flow cytometry analysis, and histological and immunohisto-
chemical  observations.  Our  experimental  results  showed  that  subcutaneously  injected 
o-MWCNT  not  only  induced  phagocytosis  of  the  local  resident  macrophages,  but  also 
competitively  recruited  macrophages  from  other  tissues.  These  interactions  resulted  in 
macrophage reduction and decreased vessel density around the tumor mass, which together 
inhibited tumor progression and metastasis in the lung. In the cell line model, the o-MWCNT 
inhibited the ability of the interleukin treated RAW macrophages to promote tumor cell 
migration as well as decreased their proliferation rate. 
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Introduction 
In  the  tissue,  macrophages  differentiate  from 
circulating monocytes and are one of the most types 
of important immune effector cells. They carry out a 
variety of functions, such as clearing cellular debris, 
responding  to  pathogens,  and  facilitating  wound 
healing. In recent years, macrophages have been re-
ported to take on different phenotypes and play dif-
ferent roles depending on the environmental signals 
that  they  receive.  When  circulating  monocytes  dif-
ferentiate in a Th1 immune environment, the resulting 
macrophages develop a classical M1 activation state; 
in  contrast,  when  monocytes  differentiate  in  a  Th2 
immune  environment,  the  alternate  M2  activation 
state is derived. In general, M1 macrophages promote 
antitumor  responses  by  activating  the  adaptive  im-
mune system, while M2 macrophages enhance tumor 
growth  by  producing  angiogenic  factors,  stromal 
breakdown  factors,  and  downregulating  antitumor 
immune  responses  [1].  On  the  spectrum  of  in  vivo 
macrophage phenotypes, M1 and M2 likely represent 
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the two extremes and have different functions. In an-
other  recent  review  of  the  full  spectrum  of  macro-
phage activation, it was suggested that macrophages 
should be classified into three major populations, in-
cluding  classically  activated  macrophages, 
wound-healing  macrophages,  and  regulatory  mac-
rophages,  because  the  M2  group  has  rapidly  ex-
panded to include essentially all macrophages that are 
not classically activated [2]. 
Aggressive or metastatic tumor cells can produce 
attractants to draw macrophages into the tumor mi-
croenvironment  and  then  educate  them  to  promote 
tumor progression [3]. These tumor-associated mac-
rophages (TAMs) are in the alternate M2 activation 
state  and  exhibit  characteristics  of  both 
wound-healing macrophages and regulatory macro-
phages,  and  produce  cytokines  and  growth  factors 
that can help tumor growth. Extensive research has 
demonstrated that macrophages in the tumor micro-
environment  are  closely  associated  with  the  devel-
opment and progression of a variety of tumors, such 
as  breast  cancer  [4-5],  prostate  [6],  glioma  [7],  lym-
phoma  [8],  bladder  [9],  lung  [10],  cervical  [11]  and 
melanoma  [12].  TAMs  have  been  investigated  as  a 
possible target for treating cancer. For example, Luo et 
al. has used RNAi technology to target legumain, a 
member of the asparaginyl endopeptidase family that 
functions as a stress protein and is overexpressed by 
TAM. Their experimental results demonstrated that a 
decrease of the number of TAMs in the tumor stroma 
effectively  altered  the  tumor  microenvironment  to 
reduce tumor angiogenesis and progression, and thus 
markedly  suppressed  tumor  growth  and  metastasis 
[13]. 
Carbon nanotubes based materials have shown 
promising  potential  in  the  biomedical  field.  Their 
possible use in novel delivery systems for drugs or 
DNA/RNA  has  been  reviewed  in  detail  by  several 
recent  publications  [14-20].  We  have  previously  re-
ported that subcutaneously injected multiwalled car-
bon nanotubes in normal BABL/c mice were largely 
engulfed by resident macrophages around the injec-
tion  site,  inducing  complement  activation  and 
short-term upregulation of some kinds of inflamma-
tory  cytokines  in  BALB/c  mice  [21];  and  in  tu-
mor-bearing BALB/c mice subcutaneous injection of 
multiwalled  carbon  nanotubes  inhibited  the  tumor 
progression  to  some  extent  [22].  When  the  multi-
walled  carbon  nanotubes  were  used  as  a  carrier  of 
tumor lysate, subcutaneous injection of this conjugate 
in tumor-bearing mice effectively increased cytotoxi-
city of the lymphocytes to the tumor cells [23]. These 
findings  imply  that  the  inhibitory  effect  of  multi-
walled carbon nanotubes on tumor progression may 
be  associated  with  their  interactions  with  macro-
phages. The aims of the present work are to investi-
gate the influence of  multiwalled carbon  nanotubes 
on macrophages in the alternative activation state in 
vitro and in the tumor-bearing mice in vivo, and to 
explore  whether  these  interactions  can  modify  the 
tumor progression. 
Materials and Methods  
Preparation  and  Characterization  of  Oxidized 
Multi-walled Carbon Nanotubes: Multi-walled carbon 
nanotubes (a-MWCNT; Chengdu Organic Chemicals 
Co. Ltd.) were prepared and characterized as previ-
ously  described  [24].  In  brief,  a-MWCNT  was  oxi-
dized in concentrated H2SO4/HNO3 (3:1 by volume) 
with sonication, followed  by  filtrating and  washing 
with large amount of pure water  to neutralize. The 
resulting  oxidized  MWCNT  (o-MWCNT)  was  dis-
persed  in  water  at  different  concentrations.  The 
o-MWCNT solution was deposited by the drop-dry 
technique for characterization by X-ray photoelectron 
spectroscopy (XPS; Japan JEOL Scientific JPS-9010TR), 
Fourier  transform  infrared  spectroscopy  (FT-IR; 
Necolet  NEXUS  670),  scanning  electron  microscopy 
(SEM; Hitachi S-5200), and thermogravimetric analy-
sis  (TGA;  TG209C,  NETZSCH).  The  solution  of 
o-MWCNT was also analyzed by UV-Vis-NIR spec-
troscopy  (Lambda  950,  Perkin-Elmer)  and  dynamic 
light scattering spectroscopy (DLS ZEN 3690; Malvern 
Instruments Ltd, Malvern, UK). 
Cell  Culture:  The  mouse  macrophage  cell  line 
RAW264.7 and mouse breast cancer cell line 4T1 were 
purchased from the Cell Bank of Shanghai Institutes 
of Biological Sciences, Chinese Academy of Sciences 
(Shanghai,  China).  RAW264.7  macrophages  were 
maintained  in  RPMI1640  media  supplemented  with 
10% fetal calf serum, 4 mM L-glutamine, 4500 mg/L 
glucose,  1500  mg/L  sodium  bicarbonate,  and  0.1% 
each  penicillin  G  and  streptomycin  (Invitrogen)  at 
37C  with  5%  CO2.  The  4T1  cell  line  is 
6-thioguanine-resistant and derived from a BALB/c 
spontaneous mammary carcinoma; it was cultivated 
in RPMI1640 supplemented with 10% fetal calf serum, 
2 mM L-glutamine, 4.5 g/L glucose, 1.5 g/L sodium 
bicarbonate,  10  mM  HEPES,  1.0  mM  sodium  py-
ruvate, and 0.1% each penicillin G and streptomycin 
at 37C with 5% CO2.  
Induction  of  Alternatively  Activated  RAW 
Macrophages by Th2 Cytokines: The RAW264.7 cell 
line  (1105)  was  treated  with  a  combination  of  10 
ng/mL each of IL-4, IL-10, and IL-13 (Peprotech) for 
72 h, with the cytokine mixture added every 24 h. The 
resulting cells were macrophages in alternative acti-
vation state, named as IL-treated RAW macrophages.  Theranostics 2012, 2(3) 
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Analysis of Surface Molecules by Flow Cytome-
try:  The  expressions  of  surface  molecules  in 
RAW264.7  cells  were  evaluated  by  flow  cytometry 
before and after treated with the combination of IL-4, 
IL-10, and IL-13. Briefly, the monolayers of IL-treated 
or the innate RAW264.7 cells were washed with cold 
phosphate buffer  solution (PBS, pH=7.4) twice, and 
then were pipetted gently avoiding creating bubbles 
to detach the cells from the Petri dishes (Corning Co.) 
by the sheer force of media flowing over the cells. The 
cells suspension were collected and were incubated 
with  rabbit  anti-mouse  monoclonal  antibodies  (an-
ti-CD68  and  anti-CD206;  Biolegend  Co.)  or  iso-
type-matched control antibodies for 1 h at 4C in the 
dark. The cells were washed  twice, followed by in-
cubation with FITC-conjugated anti-rabbit antibodies 
for 1 h. After washing twice, the cells were analyzed 
by flow cytometry (Coulter EPICS XL).  
Cell Proliferation Assays-MTS Assay: Both RAW 
and  IL-treated  RAW  macrophages  were  seeded  in 
96-well plates at a density of 4103 cells/well and cul-
tivated in an incubator overnight. The culture medi-
um was replaced with 200 µL of culture medium in 
which o-MWCNT was dispersed at concentrations of 
0.02, 0.1, and 0.5 mg/mL. The viable cell number was 
determined at 24 h, 48 h, and 72 h, using the MTS as-
say  (CellTiter  96@  AQueous  Non-Radioactive  Cell 
Proliferation Assay, Promega) according to the man-
ufacturer’s instruction. At the end of the exposure, the 
culture medium containing o-MWCNT was discarded 
and the cells were washed twice with PBS (pH=7.4). 
Thereafter, 100 μL of fresh culture medium containing 
20 μL MTS tetrazolium reagent was added to the cells. 
Plates were returned to the incubator for another 1.5 h 
at 37 °C, the culture medium was collected and the 
absorbance at 490 nm was recorded as OD value using 
a BioTek SynergyTM 4 Hybrid Multi-Mode Microplate 
Reader (BioTek Instruments, USA). In order to con-
vert the OD value into viable cells number, a linear 
calibration curve between viable cell number and ab-
sorbance at 490 nm was founded and the viable cell 
number was calculated. The cell proliferation rate was 
calculated by the following formula: cell proliferation 
rate (%) = [(average cell number of sample wells) / 
(average cell number of control wells)] 100. The in-
tact culture medium was evaluated as a control. The 
cell morphology was also observed by inverted mi-
croscope (Olympus IX71).  
Tumor Cell Migration: To measure the migration 
activity of 4T1 cells in vitro, a transwell migration as-
say was conducted in 24-well Millicell hanging cell 
culture inserts (pore size of 8 μM, Millipore). The 4T1 
cells were added to the upper chamber, and in the 
lower chamber were seeded (1) innate RAW macro-
phages alone or (2) incubated with o-MWCNT of 0.1 
mg/mL, (3) IL-treated RAW macrophages alone or (4) 
incubated with o-MWCNT of 0.1 mg/mL. After 48-h 
incubation, the 4T1 cells on the upper surface of the 
filter were carefully removed by wiping with a cotton 
swab. The membrane was allowed to dry, and then 
the migrated cells were fixed with 4% paraformalde-
hyde and stained with 0.1% crystal violet. The crystal 
violet was eluted and we measured the absorbance of 
the eluent at a wavelength of 570 nm using a BioTek 
SynergyTM 4 Hybrid Multi-Mode Microplate Reader 
(BioTek  Instruments,  USA).  The  cell  migration  rate 
was calculated by the following formula: Relative rate 
of migration (%) = [absorbance with IL-treated Raw 
macrophages  cultured  in  the  lower  cham-
ber/absorbance  with  innate  Raw  macrophages  cul-
tured in the lower chamber] × 100. The transwell as-
say was carried out at least three times.  
Animals  and  Injection  Procedure: 
Eight-week-old, female BABL/c mice were bred at the 
Experimental Animal Center at the Institute of Basic 
Medical Sciences, Chinese Academy of Medical Sci-
ences  (Beijing,  China)  under  specific  pathogen-free 
conditions.  All  the  animal  experiments  reported 
herein were carried out in compliance with the regu-
lations  of  Chinese  Academy  of  Medical  Sciences 
Standing  Committee  on  animal  experiments.  To  es-
tablish  the  tumor-bearing  mouse  model,  4T1  cell 
suspensions in PBS (pH = 7.4) were subcutaneously 
inoculated  into  the  rear  backs  of  the  naive  female 
BALB/c  mice  (2106  4T1  cells/mouse).  Most  of  the 
mice developed visible solid tumors (≥4 mm in diam-
eter) by post-inoculation day 7. The well-established 
4T1 tumor-bearing mice were randomly divided into 
2 groups: control group (n = 6) and o-MWCNT group 
(n  =  6).  The  o-MWCNT  group  was  subcutaneously 
injected twice with o-MWCNT solution at a dose of 
0.1 mg/mouse, once a week. The control group was 
injected with the same volume of water. One week 
after the second injection, three mice from each group 
were  intravenously  given  ultra  small  paramagnetic 
iron  oxide  (Sinerem®,  Laboratoire  Guerbet,  Aulnay 
sous Bois, France) at a dose of 2 μmol/mouse. The 
mice were sacrificed at 24 h post Sinerem® injection. 
The tissues surrounding the o-MWCNT injection site, 
tumor tissue, and lung tissue were excised and fixed 
in 10% neutral buffered formalin. All materials were 
sterilized before being introduced into the animals.  
Histological  and  Immunohistochemical  Analy-
sis:  After  conventional  processing,  paraf-
fin-embedded sections of subcutis, lung, and tumor 
tissues were prepared as described previously [22]. To 
evaluate  iron  location,  sections  were  stained  with 
Perl’s  stain,  which  yields  a  bright  blue  product.  In Theranostics 2012, 2(3) 
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brief, equal parts of hydrochloric acid and potassium 
ferrocyanide  were  mixed  prior  to  use.  The  sections 
were immersed in the solution for 20 minutes, washed 
well in distilled water, and counterstained with neu-
tral red for 5 minutes. The iron parts became bright 
blue and the nuclei parts became red. The lung tissue 
and tumor tissue were stained with an HE protocol. 
The  sections  of  tumor  tissue  were  also  stained  for 
CD31 antigen with a primary rabbit polyclonal anti-
body  CD31  (Beijing  Biosynthesis  and  Biotechnique 
Co., LTD China) using standard immunohistochem-
istry techniques. CD31 was detected with a DAB kit 
for  peroxidase  staining,  and  sections  were  counter-
stained with hematoxylin. The stained sections were 
subjected to microscopy (Leica DMI4000B).  
ICP-MS Assay: Subcutis and tumor tissues were 
weighted precisely and soaked in digestion solution 
consisting of high purity nitric acid, sulfuric acid, and 
perchloric acid. They were then heated at 60C and 
diluted  using  distilled  water.  Inductively  coupled 
plasma mass spectrometry (ICP-MS, Thermo ICP-MS 
XII) was applied to examine the iron content in the 
solution  and  the  iron  concentration  (μg/g)  in  each 
tissue was calculated. 
Statistical Analysis: Data are expressed as aver-
age  standard deviation (x  SD) unless otherwise 
stated.  Data  were  analyzed  using  a  student’s 
two-tailed test, assuming equal variance, with SAS 8.2 
software. 
 
Results and Discussion  
Physicochemical Characterization of o-MWCNT: 
In  order  to  understand  the  chemical  and  physical 
properties  of  the  o-MWCNT,  we  characterized  its 
features in solid state as well as dispersed in water, 
using  SEM,  DLS,  UV-vis-NIR  spectroscopy,  FTIR, 
XPS,  and  TGA.  Figure  1  displays  the  chemical  and 
physical  characteristics  of  o-MWCNT  dispersed  in 
water. A representative SEM image shows that after 
oxidization,  a-MWCNT  was  cut  short,  but  the 
tube-like structure was well maintained. By counting 
the o-MWCNT in 10 randomly selected SEM images, 
the length distribution of o-MWCNT was estimated as 
ranging from 500 nm to 2 µm, with an average length 
of 974 nm, as shown in the plots inserted in the SEM 
image. DLS data provided information about the hy-
drodynamic  diameter  of  nanotubes  as  well  as  the 
range of size distributions (Fig. 1B). Surface chemical 
features of o-MWCNT were analyzed by UV-vis-NIR 
spectroscopy,  XPS,  FTIR,  and  TGA.  Figure  1C  pre-
sents  characteristic  absorption  of  o-MWCNT  in 
240-265 nm.  
 
 
 
 
Figure 1. Physicochemical characterization of o-MWCNT. (A) Representative SEM image with inserted plot of size distribution. (B) 
Distribution of hydrodynamic diameters. (C) Absorption spectrum enveloping three resolved peaks. (D) C1s spectrum; (E) FTIR spec-
trum; and (F) TGA and DTG spectra. Theranostics 2012, 2(3) 
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In our previous work, we demonstrated that the 
spectrum could be resolved into three peaks [25], the 
intensity of peak 2 was well associated with the oxi-
dation degree of o-MWCNT, and the wavelength of 
peak 2 varied with the size distribution of o-MWCNT. 
The characteristic binding energies of o-MWCNT in 
the C1s spectrum included 284.4 eV, 285.4 eV, 286.9 
eV, 288.6 eV, and 290.8 eV (Fig. 1D), which were at-
tributed to C-C, C-O, C=O, O-C=O, and π-π, respec-
tively, indicating that a variety of oxygen-containing 
groups  had  been  introduced  to  the  surface  of 
o-MWCNT. FTIR spectroscopy provided further evi-
dence  of  the  O-C=O  group  existing  on  the  surface, 
based  on  the  characteristic  absorption  peak  of  1720 
cm-1 (Fig. 1E). Results from TGA and DTG showed 
that  the  oxidation  temperature  of  o-MWCNT  was 
504.4ºC, which was substantially lower than the tem-
perature of 651ºC for a-MWCNT (Fig. 1F). This varia-
tion in the temperature reflected defects that resulted 
from surface oxidation. 
The o-MWCNT Inhibited M2 Macrophage Pro-
liferation In Vitro: After incubation with the combina-
tion of IL4, IL10, and IL13 for 72 h, cell expression of 
CD206  was  up-regulated  (Supplementary  Material: 
Fig.  S1),  which  was  consistent  with  previously  re-
ported results and indicated that the IL-treated RAW 
macrophages had processed characteristics of tumor 
associated  macrophages  [13].  Various  assays  have 
been used to examine cells viability. Angeles Jos et al. 
[26] had applied different assay including neutral red 
uptake,  protein  content,  MTS  metabolization,  LDH 
leakage and trypan blue exclusion test to examine the 
effect  of  oxidized  single  walled  carbon  nanotubes 
(COOH-SWCNTs) on the viability of differentiated or 
non-differentiated Caco-2 cells. Their results showed 
that MTS metabolization assay and neutral red uptake 
assay were more sensitive than the others when the 
concentration range of COOH-SWCNTs was 0～1000 
μg/mL.  In  our  current  work,  the  concentration  of 
o-MWCNT  varied  from  0  to  500  μg/mL,  therefore, 
MTS assay was employed to exmine and compare the 
effect of o-MWCNT on the growth of innate RAW or 
IL-treated RAW macrophages incubated with differ-
ent concentrations of o-MWCNT for 72-h (Fig. 2).  
 
 
 
Figure 2. Influence of o-MWCNT on the proliferation of innate RAW and IL-treated RAW macrophages. (A-B) Viable cells number of 
innate RAW and IL-treated RAW macrophages after incubated with o-MWCNT at 24, 48, and 72-h. (C-E) Proliferation rate comparison 
between innate RAW and IL-treated RAW macrophages incubated with different concentration of o-MWCNT for 24, 48, and 72-h. 
*represents significant difference from innate RAW macrophages unexposed to o-MWCNT (*: p <0.05, **: p <0.01). # represents sig-
nificant difference from IL-treated RAW macrophages unexposed to o-MWCNT (#: p < 0.05, ##: p < 0.01). 
△ represents comparison 
between RAW and IL-treated RAW macrophages. n=3. 
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The starting cells number was the same for the 
innate RAW and IL-treated RAW. Except for at the 
highest  concentration  of  0.5  mg/mL,  both  innate 
RAW and IL-treated RAW macrophages proliferated 
more with prolonged incubation time, however, the 
viable cells number for IL-treated RAW macrophages 
was substantially less than that for the innate RAW 
macrophages at 24-h, 48-h, and 72-h of exposure to 
o-MWCNT  with  different  concentrations;  and  the 
highest concentration of 0.5 mg/mL inhibited prolif-
eration  of  both  innate  RAW  and  IL-treated  RAW 
macrophages  (Fig.  2A-B).  The  effect  of  o-MWCNT 
concentration  was  more  complex  (Fig.  2C-E).  The 
highest  concentration  of  0.5  mg/mL  induced  the 
strongest  inhibition  of  proliferation  of  either  innate 
RAW or IL-treated RAW macrophages at each time 
point. In further comparison, within the first 24-h in-
cubation,  proliferation  rate  of  innate  RAW  or 
IL-treated RAW macrophages was enhanced in direct 
correlation  with  the  increase  in  o-MWCNT  concen-
tration;  however,  IL-treated  RAW  macrophages  ex-
hibited obviously lower proliferation rate compared 
with  innate  RAW  macrophages.  When  incubation 
time  was  prolonged,  proliferation  rate  of  IL-treated 
RAW  macrophages  began  to  decrease  with  an  in-
crease in o-MWCNT concentration, while the prolif-
eration rate of innate RAW macrophages was changed 
little in reference to the control. These results showed 
that o-MWCNT had different effect on the prolifera-
tion rate of innate RAW and IL-treated RAW macro-
phages. As incubation time was prolonged to 48-h, in 
the concentrations  of 0.02 mg/mL and 0.1 mg/mL, 
the  o-MWCNT  inhibited  the  proliferation  rate  of 
IL-treated RAW macrophages while not affected that 
of innate RAW macrophages. 
The morphological images of innate RAW and 
IL-treated RAW macrophages after exposure to dif-
ference  concentrations  of  o-MWCNT  for  48-h  are 
shown in Figure 3. The IL-treated RAW macrophages 
became bigger in size compared to the innate RAW 
macrophages.  When  incubated  with  different  con-
centration  of  o-MWCNT,  the  IL-treated  RAW  mac-
rophages  exhibited  reduced  ability  to  engulf 
o-MWCNT  compared  to  the  innate  RAW  macro-
phages. In general the innate RAW macrophages ex-
hibited a better growth status compared to IL-treated 
RAW macrophages at each exposure concentration of 
o-MWCNT for 48-h. It could be also noticed that no 
matter exposed or not to o-MWCNT, the viable cells 
number of IL-treated RAW became less than that of 
the  innate  RAW  macrophages  after  48-h  incubation 
though they both have the same starting cells number 
of 4103. This is consistent with the results obtained 
from the MTS assay. 
The o-MWCNT Addition into IL-Treated RAW 
Cells  Inhibited  4T1  Tumor  Cell  Migration:  Macro-
phages  in  the  alternative  activation  state  primarily 
consist  of  tumor-associated  macrophages  (TAMs), 
which actually promote tumor cell proliferation and 
metastasis [27]. Here, we investigated the migration of 
4T1  breast  carcinoma  cells  when  they  were 
co-incubated in a transwell device with innate RAW 
or IL-treated RAW macrophages that were exposed to 
o-MWCNT. The results are shown in  Figure 4. The 
tumor cells in the upper well exhibited significantly 
higher migration when co-incubated with IL-treated 
RAW macrophages in the lower well, while signifi-
cantly decreased migration was observed for the tu-
mor cells when IL-treated RAW macrophages in the 
lower  well  were  exposed  to  o-MWCNT  at  the  con-
centration of 0.1 mg/ml for 48-h. These results indi-
cate that o-MWCNT altered the ability of IL-treated 
RAW macrophages to promote tumor cell migration. 
Subcutaneously  Injected  o-MWCNT  Attracted 
Macrophages: In order to examine the biodistribution 
of macrophages in the injection subcutis tissue and in 
the tumor tissue, we utilized ultra small paramagnetic 
iron  oxide (USPIO) nanoparticles as an indicator to 
show  the  variation  of  macrophages  in  the  tissues. 
USPIO  nanoparticles  are  one  type  of  contrast  for 
magnetic  resonance  (MR)  imaging  due  to  their 
cell-specificity for macrophages and usually used for 
magnetic  resonance  of  lymph  nodes  [28].  After  IV 
injection,  USPIO  nanoparticles  enter  the  interstitial 
space  from  blood  vessels  and  can  be  intracellularly 
trapped in tissue macrophages and visualized in tis-
sue by Perl’s blue staining. Therefore, the blue area 
and iron content in the tissues can indicate the dis-
tribution  and  amount  of  macrophage  in  the  tissue. 
Figure 5 presented histological observations of mice 
subcutis received IV injection of USPIO after subcu-
taneous administration of o-MWCNT injection or the 
same volume of water for one weeks. Figure 5A and 
Figure 5C gave subcutis sections stained by H & E, 
showing that the subcutaneously injected o-MWCNT 
were  taken  up  by  the  cells  and  aggregated  in  the 
subcutis. This phenomenon was also reported by our 
previous  work  that  most  subcutaneously  injected 
o-MWCNT  was  taken  up  by  resident  macrophages 
around  the  injection  site  [21-22].  It  is  interesting  to 
note  that  in  Perl’s  blue-stained  sections  there  were 
many  blue-stained  cells  in  the  subcutis  around  the 
o-MWCNT  aggregation  (Fig.  5B),  while  no  obvious 
“blue” cells could be seen in the control subcutis (Fig. 
5D).  
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Figure 3. Representative optical microscopy observations of innate RAW and IL-treated RAW macrophages incubated with o-MWCNT 
for 48-h at different concentrations.  
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Figure 4. The o-MWCNT suppressed the ability of IL-treated RAW macrophages to enhance tumor cell migration. *represents signif-
icant difference from innate RAW macrophages unexposed to o-MWCNT (*: p <0.05). 
△represents significant difference between 
IL-treated RAW macrophages un- and exposed to o-MWCNT (
△: p < 0.05). n=3. 
 
 
Figure 5. Histological observations of subcutis around subcutaneously injected o-MWCNT or water by H & E and Perl’s blue-staining. 
(A) and (B): Subcutis tissues stained by H & E and by Perl’s blue around injection site of o-MWCNT injection; (C) and (D): Subcutis tissues 
stained by H & E and by Perl’s blue around injection site of control.  Theranostics 2012, 2(3) 
 
http://www.thno.org 
266 
According to the characteristics of USPIO men-
tioned above, we considered that these blue cells were 
new coming macrophages attracted by the aggregated 
o-MWCNT  from  interstitial  space,  implying  the  ag-
gregated  o-MWCNT  attracted  macrophages  con-
stantly in the experimental period. 
The o-MWCNT Reduced Macrophages in Tumor 
Microenvironment:  Macrophages  within  the  tumor 
microenvironment are referred to as tumor-associated 
macrophages (TAMs) and most are derived from pe-
ripheral  blood  monocytes  recruited  into  the  tumor 
mass [29]. Here we examined whether the subcuta-
neously  injected  o-MWCNT  induced  variation  of 
macrophages  amount  in  the  tumor  microenviron-
ment. Fig. 6A shows an optical image of whole tumor 
mass  stained  with  Perl’s  blue,  showing  that  there 
were bright blue areas around the tumor mass.  
 
Figure 6. Subcutaneous injection of o-MWCNT reduced macrophages in the tumor microenvironment. (A) Anatomical morphology of 
tumor mass stained by Perl’s blue. (B) Histological analysis of tumor tissue stained with Perl’s blue of control mouse. (C) Histological 
analysis of tumor tissue stained with Perl’s blue of o-MWCNT injection mouse. (D) ICP-MS analysis of iron concentration in tumor mass 
of control and o-MWCNT injection mice, (n=3). (E) Immunohistochemical staining of macrophage in the tumor tissue sections with 
anti-F4/80.  Theranostics 2012, 2(3) 
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Further observation in Perl’s blue-stained tissue 
sections (Fig. 6B-C) showed there were many cells in 
intense blue in the tumor margin. When comparing 
Fig. 6B and Fig. 6C, it seemed that the tumor tissue of 
the o-MWCNT group appeared to have less blue areas 
than that of the tumor control group, and this obser-
vation was proven by the result of ICP-MS analysis 
(Fig. 6D), showing that there was less iron of USPIO 
detected in the tumor mass of the o-MWCNT group. 
The cells in blue in the tumor margin were further 
identified as macrophages by F4/80 expression (Fig. 
6E). As IV injected USPIO nanoparticles mostly enter 
the interstitial space from blood vessels and can be 
engulfed by macrophages, the results in Fig. 6 indi-
cated that there were tumor associated macrophages 
in the tumor microenvironment, and the macrophages 
number in the o-MWCNT group was less than that in 
the  control  group.  It  is  believed  that  macrophages 
within the tumor microenvironment are derived from 
peripheral blood monocytes recruited into the tumor, 
rather  than  from  local  tissue  macrophages  [29]. 
Therefore, it could be inferred that the reduction of 
macrophages  in  the  tumor  microenvironment  was 
associated with the  interaction of o-MWCNT to the 
macrophages,  which  competitively  attracted  macro-
phages with the tumor, decreasing their probability of 
entering into the tumor mass. 
The o-MWCNT Reduced Vessels in Tumor Mi-
croenvironment:  It  has  been  suggested  that  tumor 
cells “educate” macrophages in the tumor microen-
vironment to perform supportive roles that promote 
tumor  progression,  metastasis,  angiogenesis,  and 
immunosuppression  [30].  The  number  of  macro-
phages  in  the  tumor  microenvironment  is  propor-
tionally associated with formation of neovasculature 
[31]. Here, we examined vessels in the tumor micro-
environment by histological and immunohistochem-
ical observation. It was showed that there were more 
vascular  structures  around  the  tumor  mass  in  the 
control  group  than  in  the  o-MWCNT  group  (Fig. 
7A-B). This observation was proved by the results of 
statistically  counting  the  vessel  density  in  five  ran-
domly selected areas in three sections for each group 
(Fig.  7C).  Immunohistological  staining  of  vascular 
endothelium  cells  with  anti-CD31  antibody  further 
proved  that  the  vessel  density  of  the  o-MWCNT 
group  was less than  that  of the control group (Fig. 
7D-E). 
 
 
 
Figure 7. Variation of vessel density in the tumor tissues. (A) Histological analysis of vessels in HE stained tumor tissue sections of control 
mouse; (B) Histological analysis of vessels in HE stained tumor tissue sections of o-MWCNT injection mouse; Vascular structures indi-
cated by dark gray arrow heads. (C) Vessel density statistically counted under microscope, *: P<0.05. (D) Immunohistochemical analysis of 
CD31 in tumor tissue of control mouse; (E) Immunohistochemical analysis of CD31 in tumor tissue of o-MWCNT injection mouse, CD31 
positive structure was stained in brown color.  
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Fig.  8  presents  the  outcome  of  the  tumor  pro-
gression and lung metastasis status at termination of 
the  experimental  period.  Tumor  cells  in  the  control 
group  showed features  of heavy proliferation, indi-
cated by marked variation in the size and shape of 
their  nuclei,  with  hyperchromatism  and  numerous 
mitoses (Fig. 8A and C). In contrast, tumor cells in the 
o-MWCNT group exhibited shrunken nuclei and a lot 
of pores appearing in the tumor mass (Fig. 8B and D). 
The 4T1 cell is highly metastatic and lung metastasis 
was found in the control group (Figure 8E), while no 
obvious metastasis was observed in the lungs of the 
o-MWCNT group (Figure 8F). These result suggested 
that  subcutaneously  injected  o-MWCNT  had  an  in-
hibitory effect on tumor lung metastasis.  
Our  previous  investigation  demonstrated  that 
subcutaneously injected o-MWCNT upregulated the 
expression of GM-CSF and IL12p70 in the serum, the 
both obtained 2.17- fold and 2.0-fold increase [22]. The 
two  cytokines  are  typical  ones  that  are  secreted  by 
macrophages when they are activated classically and 
associated  with  anti-tumor  responses.  The  current 
work  provided  influence  of  o-MWCNT  upon  the 
macrophages  from  another  aspect.  Taken  together, 
our  investigation  demonstrated  that  the  o-MWCNT 
not only activated the macrophages in classical way to 
elicit antitumor responses, but also recruited macro-
phages to reduce macrophages in the tumor micro-
environment, which is benefit to altering tumor mi-
croenvironment and modifying tumor progression. 
 
 
Figure 8. Histological analysis of tumor and lung metastasis in the control and o-MWCNT injection mice. (A) and (C): Histological 
observation of tumor tissues of control group. (B) and (D): Histological observation of tumor tissues of o-MWCNT injection group. (E): 
Lung metastasis of control group. (D): Lung metastasis of o-MWCNT injection mice.  Theranostics 2012, 2(3) 
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Conclusion  
Subcutaneous injection of o-MWCNT in the tu-
mor-bearing mice not only attracted resident macro-
phages around the injection site and induced phago-
cytosis, but also competed with the tumor mass for 
recruitment of macrophages from circulating mono-
cytes. These interactions led to macrophages reduc-
tion and decreased vessel density around the tumor 
mass,  which  contributed  to  the  inhibition  of  tumor 
progression  and  metastasis  in  the  lung.  For  the 
IL-treated  RAW  macrophages,  o-MWCNT  sup-
pressed their ability to promote tumor cell migration, 
as well as decreased their proliferation rate. 
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